---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-087268"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:57:16.470570+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Q2 revenue $4.9M (+18% YoY), net loss $20.3M; 365-day Eversense Q4 launch on track

## Summary
- Q2 2024 revenue $4.9M, up 18% vs $4.1M in Q2 2023; U.S. revenue $3.0M (+67%), OUS $1.9M.
- Net loss $20.3M ($0.03/sh) vs $20.4M ($0.04/sh); gross profit slipped to $0.3M from $0.4M.
- FY 2024 revenue guidance unchanged at $22M-$24M; cash burn expected ~$70M, in line with 2023.
- FDA 510(k) review ongoing for 365-day Eversense; planned Q4 launch; Gemini System first-in-human testing began.
- Eon Care Services subsidiary formed; Mercy collaboration RPM service initial insertions expected Q3 2024.

## SEC filing metadata
- accession: 0001104659-24-087268
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/0001104659-24-087268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/tm2420870d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-087268
- JSON: https://secwatch.observer/filing/0001104659-24-087268.json
- Plain text: https://secwatch.observer/filing/0001104659-24-087268.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.